| Literature DB >> 30314364 |
Xiaoyan Xing1, Zhonghao Sun2, Meihua Yang3, Nailiang Zhu4, Junshan Yang5, Guoxu Ma6, Xudong Xu7.
Abstract
In this study, an improved UPLC-MS (Ultra-high performance liquid chromatography-tandem mass spectrometry) method for simultaneously quantifying twelve major components belonging to two chemical types was developed and validated, and was applied to quantitatively compare the quality of sulfur-fumigated Astragali Radix of different durations and of the fresh reference sample. The results showed that the contents of triterpenes astragaloside III and astragaloside IV decreased moderately, while the flavonoids calycosin, formononetin, and 7,2'-dihydroxy-3',4'-dimethoxyisoflavane decreased significantly. The corresponding flavonoid glycosides increased accordingly, which indicated the occurrence of chemical transformation of flavonoids and glycosides in the process of sulfur-fumigation. These transformations were further confirmed by the synthesis of flavonoid glycosides under simulated sulfur-fumigation circumstances. Furthermore, the sulfur-fumigated duration varied in proportion with the contents of compounds 7, 11, and 12. These results suggest that the established method was precise, accurate and sensitive enough for the global quality evaluation of sulfur-fumigated Astragali Radix. Further, sulfur-fumigation not only changes the proportions of bioactive components, but also causes chemical transformation in Astragali Radix.Entities:
Keywords: Astragali Radix; quantification; sulfur-fumigation duration; synthesis
Mesh:
Substances:
Year: 2018 PMID: 30314364 PMCID: PMC6222433 DOI: 10.3390/molecules23102609
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The structures of reference compounds 1–12: Eight flavonoids: Calycosin (1), calycosin-7-glucoside (2), formononetin (3), ononin (4), methylnissolin (5), astraisoflavan-7-O-β-d-glucoside (6), 7,2′-dihydroxy-3′,4′-dimethoxy-isoflavane (7), and 7,2′-dihydroxy-3′,4′-dimethoxy isoflavan-7-O-β-d-glucopyranoside (8); and four tri-terpenoid saponins: Astragaloside I (9), astragaloside II (10), astragaloside III (11), and astragaloside IV (12).
Multiple reaction monitoring (MRM) transitions and parameters for the detection of the 12 analytes.
| No. | Analyte | Precursor Ion ( | Product Ion ( | DP a (V) | CE b (V) |
|---|---|---|---|---|---|
| 1 | Calycosin | 285.2 | 213.1 | 70 | 45 |
| 2 | Calycosin-7-glucoside | 447.3 | 285.4 | 60 | 20 |
| 3 | Formononetin | 269.0 | 167.2 | 70 | 47 |
| 4 | Ononin | 431.1 | 269.1 | 65 | 20 |
| 5 | Methylnissolin | 301.2 | 167.2 | 54 | 20 |
| 6 | Astraisoflavan-7- | 463.3 | 167.4 | 60 | 40 |
| 7 | 7,2′-dihydroxy-3′,4′-dimethoxyisoflavane | 303.0 | 167.2 | 55 | 19 |
| 8 | 7,2′-dihydroxy-3′,4′-dimethoxy isoflavan-7- | 463.3 | 301.0 | −74 | −24 |
| 9 | Astragaloside I | 867.9 | 59.1 | −250 | −83 |
| 10 | Astragaloside II | 825.7 | 59.1 | −110 | −70 |
| 11 | Astragaloside III | 783.8 | 160.9 | −150 | −47 |
| 12 | Astragaloside IV | 783.8 | 101.0 | −115 | −57 |
a declustering potential; b collision Energy.
Validation with respect to linearity, limit of quantification (LOQ), limit of detection (LOD), precision, repeatability and stability.
| Analytes | Regression Equation (μg/mL) | Linear Range (μg/mL) | Correlation Coefficient (R2) | LOQ (ng/mL) | LOD (ng/mL) | Precision RSD a (%) | Repeatability RSD (%) | Stability RSD (%) | |
|---|---|---|---|---|---|---|---|---|---|
| Intra-Day | Inter-Day | ||||||||
| Calycosin | y = 446765x + 322603 | 0.4752~11.88 | 0.9989 | 0.59 | 0.06 | 2.06% | 3.16% | 4.47% | 3.93% |
| Calycosin-7-glucoside | y = 202558x + 365088 | 0.864~21.6 | 0.9992 | 1.08 | 0.11 | 1.31% | 2.09% | 3.43% | 2.95% |
| Formononetin | y = 469388x + 141426 | 0.3482~17.41 | 0.9986 | 0.87 | 0.35 | 1.65% | 1.69% | 4.09% | 3.37% |
| Ononin | y = 51545x + 4316.5 | 0.31~15.5 | 0.9994 | 3.10 | 1.55 | 1.42% | 3.86% | 4.63% | 4.05% |
| Methylnissolin | y = 329224x + 84783 | 0.6976~17.44 | 0.9993 | 0.09 | 0.02 | 1.46% | 2.53% | 4.31% | 2.99% |
| Astraisoflavan-7- | y = 130675x + 208291 | 1.5226~38.064 | 0.9991 | 0.08 | 0.04 | 2.03% | 2.78% | 4.49% | 3.73% |
| 7,2′-dihydroxy-3′,4′-dimethoxyisoflavane | y = 57437x + 11250 | 0.2571~6.427 | 0.9990 | 0.32 | 0.35 | 1.96% | 3.53% | 4.92% | 3.77% |
| 7,2′-dihydroxy-3′,4′-dimethoxy isoflavan-7- | y = 127060x + 236161 | 2.496~62.4 | 0.9988 | 0.01 | 0.001 | 1.25% | 2.37% | 3.68% | 1.50% |
| Astragaloside I | y = 1009.3x − 10607 | 8.56~214 | 0.9991 | 0.09 | 0.04 | 2.36% | 3.18% | 4.84% | 2.52% |
| Astragaloside II | y = 10750x + 25435 | 1.028~25.2 | 0.9993 | 0.03 | 0.002 | 1.65% | 3.78% | 2.66% | 2.03% |
| Astragaloside III | y = 12640x + 30515 | 1.128~28.2 | 0.9993 | 0.03 | 0.01 | 1.41% | 2.19% | 2.65% | 1.87% |
| Astragaloside IV | y = 6748.6x + 164720 | 4.584~114.6 | 0.9989 | 0.06 | 0.01 | 2.18% | 1.98% | 4.67% | 2.06% |
a relative standard deviation.
Results of recovery.
| Analyte | Initial Amount (μg) | Added Amount (μg) | Detected Amount (μg) | Recovery (%) | RSD (%) |
|---|---|---|---|---|---|
| 0.61 | 1.90 | 103.50% | 3.2 | ||
| Calycosin | 1.22 | 1.22 | 2.48 | 101.50% | 1.5 |
| 1.83 | 3.01 | 98.50% | 2.3 | ||
| 3.735 | 4.79 | 96.70% | 2.7 | ||
| Calycosin-7-glucoside | 7.47 | 7.47 | 14.51 | 97.10% | 0.9 |
| 11.205 | 19.28 | 103.20% | 1.7 | ||
| 1.21 | 3.47 | 95.40% | 1.6 | ||
| Formononetin | 2.42 | 2.42 | 5.10 | 105.20% | 3.1 |
| 3.63 | 6.01 | 99.20% | 2.7 | ||
| 0.87 | 2.61 | 99.60% | 0.4 | ||
| Ononin | 1.74 | 1.74 | 3.53 | 101.40% | 0.9 |
| 2.61 | 4.56 | 104.70% | 1.5 | ||
| 2.29 | 7.12 | 103.90% | 3.6 | ||
| Methylnissolin | 4.57 | 4.57 | 9.36 | 102.30% | 3.7 |
| 6.86 | 12.06 | 105.50% | 3.0 | ||
| 8.54 | 26.67 | 104.10% | 2.6 | ||
| Astraisoflavan-7- | 17.08 | 17.08 | 34.02 | 99.60% | 3.4 |
| 25.62 | 42.23 | 98.90% | 2.6 | ||
| 1.99 | 6.24 | 104.50% | 1.5 | ||
| 7,2′-dihydroxy-3′,4′-dimethoxyisoflavane | 3.98 | 3.98 | 8.15 | 102.30% | 1.6 |
| 5.97 | 10.11 | 101.60% | 3.2 | ||
| 1.26 | 3.87 | 102.70% | 3.1 | ||
| 7,2′-dihydroxy-3′,4′-dimethoxy | 2.51 | 2.51 | 4.96 | 98.80% | 2.3 |
| 3.77 | 6.39 | 101.80% | 5.7 | ||
| isoflavan-7- | 2.01 | 6.12 | 101.70% | 0.6 | |
| Isoflavan-7- | 4.01 | 4.01 | 7.90 | 98.40% | 2.3 |
| 6.02 | 9.58 | 95.50% | 2.6 | ||
| 1.23 | 3.79 | 103.10% | 3.1 | ||
| Astragaloside I | 2.45 | 2.45 | 4.88 | 99.60% | 4.1 |
| 3.68 | 6.06 | 98.90% | 2.8 | ||
| 1.07 | 3.16 | 98.60% | 1.5 | ||
| Astragaloside III | 2.14 | 2.14 | 4.40 | 102.90% | 2.7 |
| 3.21 | 5.30 | 99.10% | 3.1 | ||
| 4.33 | 13.50 | 104.10% | 1.8 | ||
| Astragaloside IV | 8.65 | 8.65 | 16.83 | 97.30% | 3.1 |
| 12.98 | 22.44 | 103.80% | 2.2 |
Figure 2MRM chromatograms in (A) positive and (B) negative modes. Identification: 1, calycosin; 2, calycosin-7-glucoside; 3, formononetin; 4, ononin; 5, methylnissolin; 6, astraiso-flavan-7-O-β-d-glucoside; 7, 7,2′-dihydroxy-3′,4′-dimethoxyisoflavane; 8, 7,2′-dihydroxy-3′,4′-dimethoxy; 8, isoflavan-7-O-β-d-glucopyranoside; 9, astragaloside I; 10, astragaloside II; 11, astragaloside III; 12, astragaloside IV.
The contents of twelve reference compounds in AR with and without sulfur-fumigation (mg/g, n = 3).
| Compounds | AR with and without Sulfur-Fumigation. | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 h | 2 h | 4 h | 6 h | 8 h | 12 h | 16 h | 24 h | 36 h | 48 h | 60 h | 72 h | Non-Fumigated | |
|
| 7.49 ± 0.03 | 5.04 ± 0.04 | 6.40 ± 0.02 | 7.36 ± 0.07 | 4.91 ± 0.00 | 5.97 ± 0.01 | 7.44 ± 0.10 | 5.37 ± 0.02 | 5.42 ± 0.05 | 4.86 ± 0.01 | 5.28 ± 0.06 | 6.03 ± 0.03 | 13.55 ± 0.68 |
|
| 4.24 ± 0.05 | 5.45 ± 0.02 | 5.10 ± 0.00 | 4.83 ± 0.01 | 4.61 ± 0.04 | 4.27 ± 0.02 | 4.07 ± 0.05 | 4.39 ± 0.03 | 4.33 ± 0.04 | 4.48 ± 0.01 | 3.92 ± 0.02 | 3.87 ± 0.02 | 3.21 ± 0.01 |
|
| 0.59 ± 0.01 | 0.59 ± 0.03 | 0.75 ± 0.02 | 0.78 ± 0.00 | 0.50 ± 0.02 | 0.64 ± 0.01 | 0.50 ± 0.03 | 0.62 ± 0.00 | 0.60 ± 0.02 | 0.56 ± 0.01 | 0.61 ± 0.02 | 0.63 ± 0.01 | 1.37 ± 0.04 |
|
| 0.81 ± 0.02 | 1.19 ± 0.09 | 1.04 ± 0.01 | 1.05 ± 0.04 | 0.88 ± 0.05 | 0.80 ± 0.07 | 1.06 ± 0.02 | 0.89 ± 0.00 | 0.91 ± 0.02 | 0.95 ± 0.01 | 0.76 ± 0.02 | 0.75 ± 0.01 | 0.40 ± 0.02 |
|
| 0.30 ± 0.01 | 0.25 ± 0.00 | 0.27 ± 0.02 | 0.27 ± 0.00 | 0.21 ± 0.00 | 0.22 ± 0.01 | 0.35 ± 0.02 | 0.22 ± 0.05 | 0.23 ± 0.01 | 0.22 ± 0.02 | 0.23 ± 0.00 | 0.22 ± 0.01 | 0.24 ± 0.01 |
|
| 0.55 ± 0.00 | 0.90 ± 0.01 | 0.69 ± 0.01 | 0.64 ± 0.02 | 0.59 ± 0.00 | 0.58 ± 0.05 | 0.53 ± 0.07 | 0.58 ± 0.00 | 0.52 ± 0.02 | 0.67 ± 0.00 | 0.47 ± 0.00 | 0.44 ± 0.01 | 0.32 ± 0.02 |
|
| 4.18 ± 0.06 | 2.61 ± 0.01 | 2.99 ± 0.05 | 3.44 ± 0.00 | 2.93 ± 0.02 | 3.29 ± 0.04 | 3.06 ± 0.01 | 2.51 ± 0.00 | 3.17 ± 0.02 | 2.60 ± 0.00 | 2.54 ± 0.00 | 3.24 ± 0.01 | 4.47 ± 0.10 |
|
| 0.86 ± 0.00 | 1.59 ± 0.00 | 1.38 ± 0.05 | 1.20 ± 0.07 | 1.13 ± 0.06 | 1.16 ± 0.02 | 0.95 ± 0.01 | 1.27 ± 0.00 | 1.08 ± 0.04 | 1.42 ± 0.06 | 0.97 ± 0.00 | 0.75 ± 0.00 | 0.68 ± 0.00 |
|
| 0.71 ± 0.01 | 0.74 ± 0.02 | 0.70 ± 0.00 | 0.71 ± 0.05 | 0.70 ± 0.00 | 0.70 ± 0.02 | 0.74 ± 0.04 | 0.69 ± 0.07 | 0.70 ± 0.00 | 0.68 ± 0.01 | 0.67 ± 0.02 | 0.70 ± 0.04 | 0.73 ± 0.04 |
|
| ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
|
| 0.78 ± 0.06 | 0.84 ± 0.02 | 0.79 ± 0.01 | 0.70 ± 0.04 | 0.71 ± 0.00 | 0.73 ± 0.01 | 0.75 ± 0.00 | 0.59 ± 0.02 | 0.60 ± 0.00 | 0.64 ± 0.01 | 0.57 ± 0.02 | 0.58 ± 0.01 | 0.95 ± 0.03 |
|
| 3.97 ± 0.00 | 4.17 ± 0.02 | 3.73 ± 0.01 | 3.38 ± 0.01 | 3.59 ± 0.00 | 3.53 ± 0.02 | 3.61 ± 0.01 | 2.68 ± 0.05 | 2.81 ± 0.02 | 3.03 ± 0.04 | 2.62 ± 0.00 | 2.58 ± 0.01 | 4.94 ± 0.02 |
Figure 3The synthesis of flavonoid glycosides.